Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Dr Reddy’s Eyes Generic Revlimid Exclusivity With ANDA Approval
Follows Natco ANDA Approval Earlier This Year; Market To Form In Months
Oct 19 2021
•
By
Dean Rudge
BMS anticipates 'more of a slope than a cliff' • Source: Alamy
More from Generics
More from Products